Results 101 to 110 of about 6,932 (183)

SGLT2 Inhibitors versus GLP-1 Receptor Agonists in Type 2 Diabetes, The Kidney Conundrum. [PDF]

Clin J Am Soc Nephrol
Shah J.
europepmc   +1 more source

CJN volume 35 issue 3 Cover and Back matter [PDF]

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2008
openaire   +1 more source

Authors' Reply: SGLT2 Inhibitors vs GLP-1 Receptor Agonists Type 2 Diabetes, the Kidney Conundrum. [PDF]

Clin J Am Soc Nephrol
Blum MF, Grams ME.
europepmc   +1 more source

CJN volume 29 issue 2 Cover and Front matter [PDF]

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2002
openaire   +1 more source

What the Scale Does Not Show: A Patient's Reflection on Semaglutide, Strength, and the SMART Trial. [PDF]

Clin J Am Soc Nephrol
Schumacher E.
europepmc   +1 more source

CJN volume 11 issue 1 Cover and Front matter [PDF]

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1984
openaire   +1 more source

A Beacon of Hope: Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN. [PDF]

Clin J Am Soc Nephrol
Owoyemi I, Moxey-Mims MM.
europepmc   +1 more source

Charting the Course of Recurrent C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN in Kidney Transplant Recipients. [PDF]

Clin J Am Soc Nephrol
Wong EKS.
europepmc   +1 more source

CJN volume 40 issue 5 Cover and Front matter [PDF]

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2013
openaire   +1 more source